Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01170611 · ClinicalTrials.gov registry record · Phase 4
Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease
A Phase 4 study, sponsored by LivaNova.
- Completed
- Registry status
- Phase 4
- Development phase
- 400
- Enrollment target
NCT01170611 is a Phase 4 study that has completed, run by LivaNova. The registered enrollment target is 400 participants.
The verdict
NCT01170611, a Phase 4 study, has completed, sponsored by LivaNova.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 400 participants
- Enrollment target
Study Summary
This clinical investigation is a prospective, single-blinded, randomized trial. The primary objective concerns the safety and effectiveness of the AAIsafeR mode with the preventive algorithms.
Interventions
- DEVICE PACEMAKER SYMPHONY 2550
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2004-07 |
| Est. Completion | 2007-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01170611
The ClinicalTrials.gov registry entry for NCT01170611 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LivaNova, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PACEMAKER SYMPHONY 2550 is the first listed.
NCT01170611 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01170611 about?
NCT01170611 is a clinical study titled "Prevention of Atrial Arrhythmia in Patients Without Atrioventricular (AV) Conduction Disease". This clinical investigation is a prospective, single-blinded, randomized trial. The primary objective concerns the safety and effectiveness of the AAIsafeR mode with the preventive algorithms.
What is the current status of trial NCT01170611?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 400 participants. The study started on 2004-07. Estimated completion is 2007-01.
What interventions are being tested in trial NCT01170611?
The interventions under investigation include: PACEMAKER SYMPHONY 2550 (DEVICE).
Who is sponsoring clinical trial NCT01170611?
This trial is sponsored by LivaNova, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.